中国老年乳腺癌治疗专家共识(2018)

2018-06-15 中国肿瘤科相关专家小组(统称) 协和医学杂志.2018.Jun:196-201.

老年(≥70 岁) 乳腺癌很少被临床研究所覆盖,同时老年人伴发的疾病往往复杂, 故临床实践中对于老年乳腺癌的治疗存在较多争议和不确定性。中国老年肿瘤学会乳腺分委会的治疗共识专家组就老年乳腺癌的治疗问题经过充分讨论后,本着“关键问题上达成共识, 争议问题上求同存异” 的原则,在老年乳腺癌局部治疗、辅助全身治疗、解救治疗以及新辅助治疗等问题上形成此专家共识, 以供临床医师参考。

中文标题:

中国老年乳腺癌治疗专家共识(2018)

发布日期:

2018-06-15

简要介绍:

老年(≥70 岁) 乳腺癌很少被临床研究所覆盖,同时老年人伴发的疾病往往复杂, 故临床实践中对于老年乳腺癌的治疗存在较多争议和不确定性。中国老年肿瘤学会乳腺分委会的治疗共识专家组就老年乳腺癌的治疗问题经过充分讨论后,本着“关键问题上达成共识, 争议问题上求同存异” 的原则,在老年乳腺癌局部治疗、辅助全身治疗、解救治疗以及新辅助治疗等问题上形成此专家共识, 以供临床医师参考。 



拓展指南:乳腺癌相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=中国老年乳腺癌治疗专家共识(2018))] GetToolGuiderByIdResponse(projectId=1, id=1ae481c00160606f, title=中国老年乳腺癌治疗专家共识(2018), enTitle=, guiderFrom=协和医学杂志.2018.Jun:196-201., authorId=null, author=, summary=老年(≥70 岁) 乳腺癌很少被临床研究所覆盖,同时老年人伴发的疾病往往复杂, 故临床实践中对于老年乳腺癌的治疗存在较多争议和不确定性。中国老年肿瘤学会乳腺分委会的治疗共识专家组就老年乳腺癌的治疗问题经过充分讨论后,本着“关键问题上达成共识, 争议问题上求同存异” 的原则,在老年乳腺癌局部治疗、辅助全身治疗、解救治疗以及新辅助治疗等问题上形成此专家共识, 以供临床医师参考。 , cover=, journalId=null, articlesId=null, associationId=747, associationName=中国肿瘤科相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Fri Jun 15 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=老年(≥70 岁) 乳腺癌很少被临床研究所覆盖,同时老年人伴发的疾病往往复杂, 故临床实践中对于老年乳腺癌的治疗存在较多争议和不确定性。中国老年肿瘤学会乳腺分委会的治疗共识专家组就老年乳腺癌的治疗问题经过充分讨论后,本着“关键问题上达成共识, 争议问题上求同存异” 的原则,在老年乳腺癌局部治疗、辅助全身治疗、解救治疗以及新辅助治疗等问题上形成此专家共识, 以供临床医师参考。 <br> <div><br> </div> <div><br> </div>拓展指南:<strong>与<font color=red>乳腺癌</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=6f8e51c001605677" title="2018 AIOM建议:绝经前激素受体阳性的早期乳腺癌患者辅助内分泌治疗" target=_blank>2018 AIOM建议:绝经前激素受体阳性的早期乳腺癌患者辅助内分泌治疗</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=dfc031c00159557f" title="NCCN临床实践指南:乳腺癌筛查和诊断(2018.V2)" target=_blank>NCCN临床实践指南:乳腺癌筛查和诊断(2018.V2)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=18e8a1c001593324" title="2018 NAMS/ISSWSH共识建议:绝经期乳腺癌高危女性泌尿生殖系统综合征的管理" target=_blank>2018 NAMS/ISSWSH共识建议:绝经期乳腺癌高危女性泌尿生殖系统综合征的管理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=c3f5f1c0015909a4" title="2018 南亚共识建议:乳腺癌辅助激素治疗的持续时间" target=_blank>2018 南亚共识建议:乳腺癌辅助激素治疗的持续时间</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=4135b1c001588679" title="2017 南亚实践共识建议:三阴乳腺癌的新辅助化疗" target=_blank>2017 南亚实践共识建议:三阴乳腺癌的新辅助化疗</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E4%B9%B3%E8%85%BA%E7%99%8C" target=_blank>有关乳腺癌更多指南</a></ul>, tagList=[TagDto(tagId=980, tagName=老年), TagDto(tagId=285, tagName=乳腺癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=89, categoryName=乳腺癌, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9106, appHits=441, showAppHits=0, pcHits=7179, showPcHits=2102, likes=268, shares=13, comments=5, approvalStatus=1, publishedTime=Thu Jun 21 23:01:44 CST 2018, publishedTimeString=2018-06-15, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Thu Jun 21 23:01:44 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 16:43:43 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=中国老年乳腺癌治疗专家共识(2018))])
中国老年乳腺癌治疗专家共识(2018)
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=326981, encodeId=a57232698101, content=关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Mon Jun 25 22:20:06 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326768, encodeId=586a326e683a, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Mon Jun 25 00:59:09 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326602, encodeId=dad632660289, content=好好文章学习过了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Sun Jun 24 10:54:33 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325995, encodeId=f49632599535, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Fri Jun 22 00:31:07 CST 2018, time=2018-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325970, encodeId=069d3259e001, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Thu Jun 21 23:56:49 CST 2018, time=2018-06-21, status=1, ipAttribution=)]
    2018-06-25 紫迎馨

    关注

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=326981, encodeId=a57232698101, content=关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Mon Jun 25 22:20:06 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326768, encodeId=586a326e683a, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Mon Jun 25 00:59:09 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326602, encodeId=dad632660289, content=好好文章学习过了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Sun Jun 24 10:54:33 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325995, encodeId=f49632599535, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Fri Jun 22 00:31:07 CST 2018, time=2018-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325970, encodeId=069d3259e001, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Thu Jun 21 23:56:49 CST 2018, time=2018-06-21, status=1, ipAttribution=)]
    2018-06-25 phoebeyan520

    学习了.谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=326981, encodeId=a57232698101, content=关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Mon Jun 25 22:20:06 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326768, encodeId=586a326e683a, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Mon Jun 25 00:59:09 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326602, encodeId=dad632660289, content=好好文章学习过了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Sun Jun 24 10:54:33 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325995, encodeId=f49632599535, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Fri Jun 22 00:31:07 CST 2018, time=2018-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325970, encodeId=069d3259e001, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Thu Jun 21 23:56:49 CST 2018, time=2018-06-21, status=1, ipAttribution=)]
    2018-06-24 139****5926

    好好文章学习过了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=326981, encodeId=a57232698101, content=关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Mon Jun 25 22:20:06 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326768, encodeId=586a326e683a, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Mon Jun 25 00:59:09 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326602, encodeId=dad632660289, content=好好文章学习过了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Sun Jun 24 10:54:33 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325995, encodeId=f49632599535, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Fri Jun 22 00:31:07 CST 2018, time=2018-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325970, encodeId=069d3259e001, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Thu Jun 21 23:56:49 CST 2018, time=2018-06-21, status=1, ipAttribution=)]
    2018-06-22 sunfeifeiyang

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=326981, encodeId=a57232698101, content=关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/11/eb1f237032e0bf07b10833fc3722e645.jpg, createdBy=2fed2145219, createdName=紫迎馨, createdTime=Mon Jun 25 22:20:06 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326768, encodeId=586a326e683a, content=学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1bb241978, createdName=phoebeyan520, createdTime=Mon Jun 25 00:59:09 CST 2018, time=2018-06-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=326602, encodeId=dad632660289, content=好好文章学习过了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K1RUfOKQohib4bXhDtxVgOA9VcKY1LUZkCOmr0v3WupxANz2ibibNHkdevtSruvrhyI29IjXdtvUV48/0, createdBy=6ff82057534, createdName=139****5926, createdTime=Sun Jun 24 10:54:33 CST 2018, time=2018-06-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325995, encodeId=f49632599535, content=阅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/09/07/a9772c74ffd6edc03a7f9af07b4747f6.jpg, createdBy=b3722138742, createdName=sunfeifeiyang, createdTime=Fri Jun 22 00:31:07 CST 2018, time=2018-06-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=325970, encodeId=069d3259e001, content=谢谢分享学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Thu Jun 21 23:56:49 CST 2018, time=2018-06-21, status=1, ipAttribution=)]
    2018-06-21 清风拂面

    谢谢分享学习

    0